FDA regulatory routes and clinical post-marketing requirements for personalized medicines

被引：0
|
作者：
Vossen, Carla [1 ]
Albano, Jessica [1 ]
Isherwood, Tara [1 ]
机构：
[1] Syneos Hlth, Morrisville, NY USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [31] Post-marketing Surveillance Why the FDA can't protect the public
    Lenzer, Jeanne
    Brownlee, Shannon
    BMJ-BRITISH MEDICAL JOURNAL, 2010, 341
  • [32] Post-marketing surveillance of anti-malarial medicines used in Malawi
    Chikowe, Ibrahim
    Osei-Safo, Dorcas
    Harrison, Jerry J. E. K.
    Konadu, Daniel Y.
    Addae-Mensah, Ivan
    MALARIA JOURNAL, 2015, 14
  • [33] Post-marketing drug withdrawals: Pharmacovigilance success, regulatory problems
    Aronson, Jeffery K.
    THERAPIE, 2017, 72 (05): : 555 - 561
  • [34] Scarce quality assurance documentation in major clinical trial registries for approved medicines used in post-marketing clinical trials
    Yorokpa Joachim Doua
    Hanneke Dominicus
    Julius Mugwagwa
    Suzelle Magalie Gombe
    Jude Nwokike
    Trials, 20
  • [35] Scarce quality assurance documentation in major clinical trial registries for approved medicines used in post-marketing clinical trials
    Doua, Yorokpa Joachim
    Dominicus, Hanneke
    Mugwagwa, Julius
    Gombe, Suzelle Magalie
    Nwokike, Jude
    TRIALS, 2019, 20 (1)
  • [36] CHANGES IN FDA POST-MARKETING COMMITMENTS TO SUPPORT THE PREGNANCY AND LACTATION LABELING RULE
    Covington, D.
    Buus, R.
    Mabe, B.
    VALUE IN HEALTH, 2018, 21 : S147 - S147
  • [37] Status and Development Trend of Evaluation of Post-Marketing Traditional Chinese Medicines in China
    魏瑞丽
    王志飞
    谢雁鸣
    World Journal of Integrated Traditional and Western Medicine, 2020, 6 (06) : 15 - 22
  • [38] Post-marketing biopharmaceutical evaluation of dipyrone tablets: reference, generic and similar medicines
    dos Santos, Eliane Silva
    Teles Cardoso, Amanda dos Santos
    Laignier Cazedey, Edith Cristina
    VIGILANCIA SANITARIA EM DEBATE-SOCIEDADE CIENCIA & TECNOLOGIA, 2021, 9 (03): : 58 - 68
  • [39] Development of Post-Marketing Risk Management Plan Requirements: The Singapore Experience
    Tan, Liesbet Li-Bei
    Ho, Christine Su-Ching
    Han, Phey-Yen
    Chan, Cheng-Leng
    PHARMACEUTICAL MEDICINE, 2018, 32 (01) : 13 - 20
  • [40] Tolerability of sumatriptan: clinical trials and post-marketing experience
    Welch, KMA
    Mathew, NT
    Stone, P
    Rosamond, W
    Saiers, J
    Gutterman, D
    CEPHALALGIA, 2000, 20 (08) : 687 - 695
12345